Adjuvant therapy of melanoma: what's new?
Ascierto
P A
PA
Palmieri
G
G
Daponte
A
A
Melucci
M T
MT
Satriano
R A
RA
Mozzillo
N
N
Castello
G
G
D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008197:Lymph Node Excision; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016019:Survival Analysis; D016896:Treatment Outcome
D007155:Immunologic Factors; D016898:Interferon-alpha